Pinnacle III Promotes Robert Carrera to President and CEO, Moves Offices to Denver
Robert Carrera has been appointed president and CEO of the company. In his new role, he will focus on the company's strategic direction and oversee operations, including financial management and product line evaluation. Mr. Carrera has more than 25 years of healthcare experience, 15 of which were spent developing and managing ASCs.
Richard DeHart, co-founder of Pinnacle III and previously the company's CEO, will continue to work with Mr. Carrera on strategic direction and client services.
"As Pinnacle III transitioned its base of operations from Fort Collins to Denver, we recognized a need to optimize staff responsibilities for the benefit of our clients and internal operations," said Scott Thomas, executive vice president of Pinnacle III. "Carrera and DeHart are both respected leaders in the industry and have nearly 40 years of combined experience managing ASCs. Their expertise has been essential to developing the results-oriented services Pinnacle III prides itself on and we look forward to their leadership in the future."
Learn more about Pinnacle III.
Related Articles on Pinnacle III:
10 Steps to Maximize Reimbursement for Total Joint Replacement at Surgery Centers
3 Tough Benchmarking Goals for ASCs and How to Meet Them
10 Good Ideas to Grow Single-Specialty Surgery Center Case Volume
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- The Changing Healthcare Environment & Gastroenterologists: Q&A With Dr. Edwin Levine
- ASC vs. HOPD Cost Compare in Virginia: 13 Statistics
- SourceMedical Names Ann Geier Vice President-Clinical Informatics
- 6 Recent Key Notes on ASC Management & Development Companies – Northstar Healthcare, Physicians Endoscopy, USPI & More
- SGR Repeal to Cost $153.2B: CBO